MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT-signaling in dendritic cells after stem cell transplantation

[1]  C. Lengerke,et al.  Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey , 2015, Leukemia.

[2]  Xin Huang,et al.  MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins* , 2014, The Journal of Biological Chemistry.

[3]  J. Duyster,et al.  MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. , 2014, Blood.

[4]  C. Peschel,et al.  Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease. , 2014, Blood.

[5]  Yan Yang,et al.  Meta-analysis of pre-miRNA polymorphisms association with susceptibility to autoimmune diseases , 2014, Immunological investigations.

[6]  A. Vaiopoulou,et al.  Association Study of Genetic Variants in miRNAs in Patients with Inflammatory Bowel Disease: Preliminary Results , 2013, Digestive Diseases and Sciences.

[7]  J. Wingard,et al.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  U. Testa,et al.  The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer , 2012, Journal of Hematology & Oncology.

[9]  L. Truedsson,et al.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene , 2012, Genes and Immunity.

[10]  B. Malissen,et al.  Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease , 2011, Nature Medicine.

[11]  David Baltimore,et al.  Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.

[12]  H. Strobl,et al.  miR-146a Is Differentially Expressed by Myeloid Dendritic Cell Subsets and Desensitizes Cells to TLR2-Dependent Activation , 2010, The Journal of Immunology.

[13]  C. Harding,et al.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors , 2010, Nature Reviews Microbiology.

[14]  Kaleb M. Pauley,et al.  miR-146a Is Critical for Endotoxin-induced Tolerance , 2009, The Journal of Biological Chemistry.

[15]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[16]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[17]  F. Ginhoux,et al.  Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men , 2006, The Journal of experimental medicine.

[18]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[19]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[20]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[21]  S. Ebong,et al.  Dendritic Cell Maturation Requires STAT1 and Is under Feedback Regulation by Suppressors of Cytokine Signaling , 2004, The Journal of Immunology.

[22]  J. Crawford,et al.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. , 2001, The Journal of clinical investigation.

[23]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[24]  D. Sedmak,et al.  Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway , 1998, The Journal of experimental medicine.

[25]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[26]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[27]  M. Merad,et al.  Dendritic cells in transplantation and immune-based therapies. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.